journal
https://read.qxmd.com/read/37691268/paprika-a-question-bank-for-assessing-psoriatic-arthritis-risk-in-individuals-of-diverse-ancestries
#21
JOURNAL ARTICLE
Jessica A Walsh, Courtney Carroll, Kristina Callis Duffin, Jing Wang, Gerald G Krueger, Bing-Jian Feng
OBJECTIVE: To create a question bank about clinical factors for predicting the diagnosis of psoriatic arthritis in psoriasis patients of various ancestries and skin tones, which can be completed entirely by patients. METHODS: Utah Psoriasis Initiative participants without psoriatic arthritis diagnosis at enrollment were followed for diagnosis during the study period. We inferred ancestry from exome sequencing data and performed Cox proportional hazards regression to identify clinical predictors of psoriatic arthritis in different ancestry groups...
September 10, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37691141/decline-in-incidence-of-extraarticular-manifestations-of-rheumatoid-arthritis-a-population-based-cohort-study
#22
JOURNAL ARTICLE
Bradly A Kimbrough, Cynthia S Crowson, John M Davis, Eric L Matteson, Elena Myasoedova
OBJECTIVE: To assess changes in the cumulative incidence of extraarticular manifestations of rheumatoid arthritis (ExRA) and associated mortality risk. METHODS: This study evaluated trends in occurrence of ExRA using a population-based inception cohort that included all adult patients with incident RA from 1985 through 2014 meeting the 1987 American College of Rheumatology criteria. Patients were divided into two cohorts based on the incidence date of RA, 1985-1999 and 2000-2014...
September 10, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37667975/comorbidities-in-early-psoriatic-arthritis-data-from-metapsa-cohort-study
#23
JOURNAL ARTICLE
Alla Ishchenko, Sofia Pazmino, Barbara Neerinckx, Rik Lories, Kurt de Vlam
OBJECTIVES: The aim of this study was to investigate prevalence of comorbidities and cardiovascular risk factors (CV RFs) in early, treatment naïve psoriatic arthritis (PsA) and to identify factors that contribute to the metabolic burden in early PsA (ePsA). METHODS: This was an observational longitudinal multicenter cohort study. Clinical, demographic characteristics, CV RF and comorbidities were compared in newly diagnosed PsA patients and sex- and age-matched controls...
September 5, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37667586/capturing-patient-value-in-an-economic-evaluation
#24
JOURNAL ARTICLE
Fiona Koster, Marc R Kok, Deirisa Lopes Barreto, Angelique E A M Weel-Koenders
OBJECTIVE: Economic evaluations predominantly use generic outcomes, such as EuroQol-5 Dimension (EQ-5D), to assess the health status. However, because of the generic nature, they are less suitable to capture the quality of life of patients with specific conditions. Given the transition to patient-centered (remote) care delivery, this study aims to evaluate the possibility to use disease-specific measures in a cost-effectiveness analysis (CEA). METHODS: A real-life cohort from Maasstad Hospital (2020-2021) in the Netherlands, with 772 Rheumatoid Arthritis (RA) patients, was used to assess the cost-effectiveness of electronic consultations (e-consultations) compared with face-to-face consultations...
September 4, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37667434/a-reference-range-of-hydroxychloroquine-blood-levels-that-can-reduce-odds-of-active-lupus-and-prevent-flares
#25
JOURNAL ARTICLE
Shivani Garg, Betty Chewning, Paul Hutson, Brad C Astor, Christie M Bartels
OBJECTIVE: Recent data show that lower hydroxychloroquine (HCQ) doses are associated with two-six-fold higher risk of lupus flare. Thus, establishing an effective a reference range of HCQ blood levels with upper and lower bounds for efficacy may support individualizing HCQ dosing to prevent flares. METHODS: HCQ levels in whole blood and SLE disease activity index (SLEDAI) were measured during the baseline visit and again during a standard of care routine follow-up visit...
September 4, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37667424/does-the-impact-of-covid-19-on-patients-with-systemic-sclerosis-change-over-time
#26
JOURNAL ARTICLE
Elisabeth Deibel, Patricia E Carreira, Madelon Vonk, Nicoletta Del Papa, Radim Bečvář, Alfredo Guillén-Del-Castillo, Corrado Campochiaro, Hadi Poormoghim, Sophie Liem, Maria-Grazia Lazzaroni, Alessandro Giollo, Arsène Mekinian, Jeska de Vries-Bouwstra, Maria De Santis, Alexandra Balbir-Gurman, Carina Mihai, Giacomo De Luca, Sergey Moiseev, Elisabetta Zanatta, Rosario Foti, Simona Rednic, Christopher Denton, Maurizio Cutolo, Laura Belloli, Paolo Airo, Liudmila Garzanova, Gianluca Moroncini, Murat İnanç, Stylianos Panopoulos, Jose-Luis Tandaipan, Emmanuel Chatelus, Edoardo Rosato, Masataka Kuwana, Sule Yavuz, Juan J Alegre-Sancho, Vanessa Smith, Gabriella Szűcs, Joerg Henes, Ignasi Rodríguez-Pintó, Fabiola Atzeni, Julia Spierings, Marie-Elise Truchetet, Marcin Milchert, Daniel Brito de Araujo, Gabriela Riemekasten, Vera Bernardino, Thierry Martin, Francesco Del Galdo, Alessandra Vacca, Fabian Mendoza, Øyvind Midtvedt, Giuseppe Murdaca, Tânia Santiago, Veronica Codullo, Fabio Cacciapaglia, Ulrich Walker, Cathrine Brunborg, Francesca Tirelli, Yannick Allanore, Daniel E Furst, Marco Matucci, Armando Gabrielli, Oliver Distler, Anna-Maria Hoffmann-Vold
OBJECTIVE: Outcome of COVID-19 patients improved over the pandemic, including patients with systemic rheumatic diseases. However, data on systemic sclerosis (SSc) patients are lacking. This study aimed to assess the outcome of SSc patients with COVID-19 over several waves. METHODS: SSc patients with COVID-19 registered in the European Scleroderma Trials and Research group (EUSTAR) were collected between April 2020 and April 2021. Patients were assigned to wave 1 to 3 depending on date of COVID-19...
September 4, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37652871/development-of-an-interactive-tool-to-support-shared-decision-making-in-rheumatoid-arthritis-treatment-attribute-preference
#27
JOURNAL ARTICLE
Jeffrey R Curtis, Kerri Ford, Stefano Fiore, Ted R Mikuls, Kevin Shaney, Vaneet Sethi
OBJECTIVE: An interactive tool identifying treatment attributes important to patients can enhance shared decision making (SDM) in rheumatoid arthritis (RA). A formative survey was conducted to identify the most important treatment attributes from patients' perspective, which can be used to develop an interactive SDM tool. METHODS: The survey was performed in two phases: qualitative interviews and quantitative surveys. The qualitative interviews were conducted to inform the design of the quantitative survey...
August 31, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37652750/multivalvular-cardiac-disease-in-a-young-woman-with-hypocomplementemic-urticarial-vasculitis
#28
JOURNAL ARTICLE
Samuel D Good, Vilasinee Rerkpichaisuth, Michael C Fishbein, Abbas Ardehali, Tanaz A Kermani
No abstract text is available yet for this article.
August 31, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37652748/the-use-of-remote-consultations-and-associated-factors-a-large-retrospective-cohort-study-of-follow-up-consultations-before-during-and-after-covid-19
#29
JOURNAL ARTICLE
Jeffrey van der Ven, Bart Jf van den Bemt, Sabien Wielsma, Marcel Flendrie, Lise M Verhoef
OBJECTIVES: To investigate the use of remote consultations (RCs) and the influence of consultation, healthcare provider (HCP) and patient characteristics on the choice for remote or face-to-face consultation. METHODS: A monocenter retrospective cohort study was conducted on follow-up consultations of patients with rheumatic diseases from 2019-01-01 to 2023-01-16, using data from electronic health records. Trends in the proportion of RCs before, during and after COVID-19 were studied...
August 31, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37643919/incidence-of-pneumocystis-jiroveci-pneumonia-in-patients-with-anca-associated-vasculitis-initiating-therapy-with-rituximab-or-cyclophosphamide
#30
JOURNAL ARTICLE
Elizabeth Nettleton, Sebastian E Sattui, Zachary Wallace, Michael Putman
OBJECTIVE: This manuscript assesses the incidence of Pneumocystis jiroveci pneumonia (PJP) among patients receiving contemporary treatment regimens for ANCA-associated vasculitis (AAV) and adverse events associated with PJP prophylaxis. METHODS: Incident users of rituximab or cyclophosphamide for AAV were identified in the TriNetX electronic health records database from 2011-2022. The incidence rates (IR) of PJP in the first six months of induction therapy with rituximab and/or cyclophosphamide and during post-induction maintenance therapy with rituximab were calculated...
August 29, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37643903/impact-of-risk-factors-on-covid-19-outcomes-in-unvaccinated-people-with-rheumatic-diseases
#31
JOURNAL ARTICLE
Jinoos Yazdany, Anna Ware, Zachary S Wallace, Suleman Bhana, Rebecca Grainger, Eric Hachulla, Christophe Richez, Patrice Cacoub, Jonathan S Hausmann, Jean W Liew, Emily Sirotich, Lindsay Jacobsohn, Anja Strangfeld, Elsa F Mateus, Kimme L Hyrich, Laure Gossec, Loreto Carmona, Saskia Lawson-Tovey, Lianne Kearsley-Fleet, Martin Schaefer, Sandra Lucia Euzebio Ribeiro, Samar Al-Emadi, Rebecca Hasseli, Ulf Müller-Ladner, Christof Specker, Hendrik Schulze-Koops, Miguel Bernardes, Vanessa Machado Fraga, Ana Maria Rodrigues, Jeffrey A Sparks, Lotta Ljung, Daniela Di Giuseppe, Liselotte Tidblad, Leanna Wise, Alí Duarte-García, Manuel F Ugarte-Gil, Iris Jazmín Colunga-Pedraza, Marco Ulises Martínez-Martínez, Deshire Alpizar-Rodriguez, Ricardo Machado Xavier, Carolina A Isnardi, Mariana Pera, Guillermo Pons-Estel, Zara Izadi, Milena A Gianfrancesco, Greta Carrara, Carlo Alberto Scirè, Anna Zanetti, Pedro M Machado
BACKGROUND: Approximately one-third of individuals worldwide have not received a COVID-19 vaccine. While studies have investigated risk factors linked to severe COVID-19 among unvaccinated people with rheumatic diseases(RD), we know less about whether these factors changed as the pandemic progressed. We aimed to identify risk factors associated with severe COVID-19 in unvaccinated individuals in different pandemic epochs corresponding to major variants of concern. METHODS: Patients with RD and COVID-19 were entered into the COVID-19 Global Rheumatology Alliance registry between March 2020 and June 2022...
August 29, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37605840/incidence-rate-and-factors-associated-with-fractures-among-medicare-beneficiaries-with-ankylosing-spondylitis-in-the-united-states
#32
JOURNAL ARTICLE
Rachael Stovall, Emma Kersey, Jing Li, Rahaf Baker, Christine Anastasiou, Andriko Palmowski, Gabriela Schmajuk, Lianne Gensler, Jinoos Yazdany
OBJECTIVE: We evaluated the incidence rate and factors associated with fractures among adults with ankylosing spondylitis (AS). METHODS: We performed a retrospective cohort study with data from the Rheumatology Informatics System for Effectiveness (RISE) registry linked to Medicare claims from 2016-2018. Patients were required to have two AS ICD codes, ≥30 days apart, and a subsequent Medicare claim. Then, one year of baseline characteristics were included, after which patients were observed for fractures...
August 22, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37605835/humoral-and-t-cell-response-to-sars-cov-2-vaccination-in-patients-with-rheumatoid-arthritis
#33
JOURNAL ARTICLE
Carolina A Isnardi, Margarita Landi, Leonel Cruces, Pablo Maid, Claudia Calle Montoro, María A Alfaro, Brian M Roldán, Andrea B Gómez Vara, Pamela Giorgis, Roberto A Ezquer, María G Crespo Rocha, Camila R Reyes Gómez, María Á Correa, Osvaldo L Cerda, Marcos G Rosemffet, Virginia Carrizo Abarza, Santiago Catalan Pellet, Miguel Perandones, Cecilia Reimundes, Yesica Longueira, Gabriela Turk, María F Quiroga, Natalia Laufer, María C De La Vega, Gustavo Citera, Guillermo J Pons-Estel, Emilce E Schneeberger
OBJECTIVE: To assess the SARS-CoV-2-specific humoral and T-cell response after a two-dose regimen of SARS-CoV-2 vaccine in patients with rheumatoid arthritis (RA). METHODS: In this observational study, patients with RA, ≥18 years old, vaccinated for SARS-CoV-2 according to the Argentine National Health Ministry´s vaccination strategy were included. Anti-SARS-CoV-2 IgG antibodies (ELISA-COVIDAR test), neutralizing activity (cytotoxicity in VERO cells) and specific T-cell response (IFN-γ ELISpot Assay) were assessed after the first and second dose...
August 22, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37587869/diagnostic-accuracy-study-of-the-pediatric-specific-ultrasound-scoring-system-for-the-knee-joint-in-children-with-juvenile-idiopathic-arthritis
#34
JOURNAL ARTICLE
Patricia Vega-Fernandez, Kelly Rogers, Alyssa Sproles, Sherry Thornton, Jennifer Huggins, Daniel J Lovell, Amy Cassedy, Arthur B Meyers, Tracy V Ting
OBJECTIVE: To validate the Pediatric Arthritis Ultrasound Scoring System for the knee joint (PAUSS-knee) in children with juvenile idiopathic arthritis (JIA). METHODS: Children with JIA prospectively received a musculoskeletal ultrasound (MSUS) examination of the knee and a physical examination to determine presence/absence of clinical arthritis were enrolled in this study. MSUS images were scored using the PAUSS-knee, a semiquantitative MSUS scoring system (0-normal to 3-severe) for B-mode and Power Doppler-mode...
August 17, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37563733/structural-foot-characteristics-in-people-with-midfoot-osteoarthritis-cross-sectional-findings-from-the-clinical-assessment-study-of-the-foot-structural-foot-characteristics-in-people-with-midfoot-osteoarthritis-cross-sectional-findings-from-the-clinical-assessment
#35
JOURNAL ARTICLE
Merridy J Lithgow, Andrew K Buldt, Shannon E Munteanu, Michelle M Marshall, Martin J Thomas, George Peat, Edward Roddy, Hylton B Menz
OBJECTIVE: To compare radiographic measures of foot structure between people with and without symptomatic radiographic midfoot osteoarthritis (OA). METHODS: This was a cross-sectional study of adults aged ≥50 years registered with four UK general practices who reported foot pain in the past year. Bilateral weightbearing dorsoplantar and lateral radiographs were obtained. Symptomatic radiographic midfoot OA was defined as midfoot pain in the last four weeks, combined with radiographic OA in one or more midfoot joints (first cuneometatarsal, second cuneometatarsal, navicular-first cuneiform and talonavicular)...
August 10, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37563714/treatment-of-polymyalgia-rheumatica-by-rheumatology-providers-analysis-from-the-acr-rheumatology-informatics-system-for-effectiveness-registry
#36
JOURNAL ARTICLE
Sebastian E Sattui, Fenglong Xie, Zihan Wan, Cassie Clinton, Robyn T Domsic, Jeffrey R Curtis
OBJECTIVE: To describe the demographics, comorbidities, and treatment patterns in a national cohort of patients with polymyalgia rheumatica (PMR) receiving care from rheumatology providers. METHODS: Patients with PMR were identified in the ACR Rheumatology Informatics System for Effectiveness (RISE) registry from 2016-2022. Use of glucocorticoids and immunomodulatory antirheumatic medications used as steroid-sparing agents were examined overall, and in a subgroup of patients new to rheumatology practices, the majority with presumed new-onset PMR...
August 10, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37553607/covid-19-vaccination-and-gout-flare-risk-in-patients-with-infrequent-or-frequent-flares-a-prospective-cohort-study
#37
JOURNAL ARTICLE
Yuwei He, Xiaomei Xue, Nicola Dalbeth, Robert Terkeltaub, Ying Chen, Fei Yan, Lei Pang, Xinde Li, Xuan Yuan, Xiaoyu Cheng, Changgui Li, Mingshu Sun
OBJECTIVES: To assess post-COVID-19 vaccination gout flare risk with differing baseline flare burden. METHODS: We prospectively studied gout patients with infrequent or frequent flares, defined as ≤1 flare/year, or ≥2 flares/year, respectively. COVID-19 vaccine-naïve patients managed with urate-lowering therapy between February-June 2021were included, and voluntarily decided on vaccination. Participants were followed for 12 weeks after enrollment or first vaccine dose...
August 8, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37544733/reflections-on-the-covid-19-pandemic-advance-practice-providers-the-multi-tools-of-rheumatology
#38
EDITORIAL
Kori Dewing
No abstract text is available yet for this article.
August 6, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37533231/reflections-on-the-covid-19-pandemic-impacts-on-clinical-rheumatology-research
#39
EDITORIAL
Katie F Huffman, Kimberlea F Grimm, Kelli D Allen
No abstract text is available yet for this article.
August 2, 2023: Arthritis Care & Research
https://read.qxmd.com/read/37525488/applying-lessons-from-rheumatology-to-better-understand-long-covid
#40
REVIEW
Don L Goldenberg
Long COVID can sometimes be attributed to organ damage and well-characterized pathophysiology, but more often there is no evidence of organ damage or abnormal biomarkers. This is most evident in patients with mild to moderate initial SARS-CoV-2 infection who were not hospitalized. Their persistent symptoms are strikingly similar to those of fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), including fatigue, post exertional malaise, myalgias/arthralgias, sleep and cognitive disturbances in 50-100% of cases...
July 31, 2023: Arthritis Care & Research
journal
journal
42635
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.